Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ZYME - Zymeworks Inc.


IEX Last Trade
12.54
0   0%

Share volume: 0
Last Updated: Fri 20 Dec 2024 09:14:05 PM CET
Research and Development in Biotechnology (except Nanobiotechnology): 0.46%

PREVIOUS CLOSE
CHG
CHG%

$12.54
0.73
0.05%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-03-31 2022-06-30
Fiscal Quarter Q1 2022 Q2 2022
Report Date 2022-05-04 2022-08-04
Total revenue 1.916 M 5.442 M
Cost of revenue 0.000 0.000
Gross profit 1.916 M 5.442 M
    184.03%  
Operating expenses 74.602 M 71.265 M
Selling general and admin 12.092 M 15.243 M
Research and development 62.510 M 56.022 M
Total expenses 74.602 M 71.265 M
    -4.47%  
Operating income -72.686 M -65.823 M
Ebit -72.686 M -65.823 M
Pretax income -72.699 M -64.628 M
    -11.10%  
Income tax -74.000 K -9.000 K
Net income basic -72.625 M -64.619 M
    11.02%  
Net income -72.625 M -64.619 M
    11.02%